東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Clinical and economic impacts of a p...

Doan, QuynhChau Diem.

FindBook

Google Book

Amazon

博客來

Clinical and economic impacts of a pharmacist-managed anticoagulation clinic.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Clinical and economic impacts of a pharmacist-managed anticoagulation clinic./
作者:	Doan, QuynhChau Diem.
面頁冊數:	412 p.
附註:	Adviser: Marvin D. Shepherd.
Contained By:	Dissertation Abstracts International67-06B.
標題:	Health Sciences, Pharmacy. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3223007
ISBN:	9780542732911

Clinical and economic impacts of a pharmacist-managed anticoagulation clinic.
Doan, QuynhChau Diem.

Clinical and economic impacts of a pharmacist-managed anticoagulation clinic. - 412 p.

Adviser: Marvin D. Shepherd.

Thesis (Ph.D.)--The University of Texas at Austin, 2006.

This study evaluated the impact of a pharmacist-managed anticoagulation clinic (AC) on the clinical and economic outcomes of patient newly treated with warfarin therapy. A retrospective chart review was conducted for patients initiating warfarin therapy between November 1997 and April 1998. Patients were maintained on warfarin therapy for a minimum of two months. Patients were followed for either one-year post-initiation of warfarin usage or until discontinuation of warfarin therapy, whichever occurred earlier.

ISBN: 9780542732911Subjects--Topical Terms:

1017737
Health Sciences, Pharmacy.

Clinical and economic impacts of a pharmacist-managed anticoagulation clinic.
LDR:03157nam 2200289 a 45 001 964049
005 20110901
008 110901s2006 eng d
020 $a 9780542732911
035 $a (UMI)AAI3223007
035 $a AAI3223007
040 $a UMI $c UMI
100 1 $a Doan, QuynhChau Diem. $3 1287121
245 1 0 $a Clinical and economic impacts of a pharmacist-managed anticoagulation clinic.
300 $a 412 p.
500 $a Adviser: Marvin D. Shepherd.
500 $a Source: Dissertation Abstracts International, Volume: 67-06, Section: B, page: 3082.
502 $a Thesis (Ph.D.)--The University of Texas at Austin, 2006.
520 $a This study evaluated the impact of a pharmacist-managed anticoagulation clinic (AC) on the clinical and economic outcomes of patient newly treated with warfarin therapy. A retrospective chart review was conducted for patients initiating warfarin therapy between November 1997 and April 1998. Patients were maintained on warfarin therapy for a minimum of two months. Patients were followed for either one-year post-initiation of warfarin usage or until discontinuation of warfarin therapy, whichever occurred earlier.
520 $a Data were analyzed for 65 AC and 99 usual care (UC) patients. Anticoagulation clinic patients had a greater proportion of international normalized ratio (INR) values that were within therapeutic range than UC patients (61.3% and 56.9% of INR values, respectively) and a greater number of days with INR values in therapeutic range than UC patients (56.2% of days for AC patients and 48.8% of days for UC patients). The incidence rates of warfarin-related events were similar in both groups. Total charges for all health care services during the follow-up period were 50 percent greater for UC patients than for AC patients ( $2 ,012.97 and $9 52.65 per UC and AC patient-month, respectively; p<0.05). Despite a higher mean number of days hospitalized per patient-month for AC patients for warfarin-related events, charges for warfarin-related inpatient admissions were lower for AC patients than UC patients ( $2 39 per patient-month for the AC group and $3 70 per patient-month for the UC group). Charges for non-warfarin-related inpatient admissions and the mean incidence rates for non-warfarin-related hospitalizations and outpatient visits were also less for AC patients than UC patients. Usual care patients were more than twice as likely as AC patients to be prescribed a medication that could potentially interact with warfarin therapy. The rates of adherence to warfarin therapy, as measured by the medication possession ratio, were similar for both groups.
520 $a Anticoagulation clinic patients experienced better anticoagulation control, incurred fewer overall charges for warfarin-related and non-warfarin-related health care services, and were less likely to experience drug interactions with warfarin therapy than UC patients.
590 $a School code: 0227.
650 4 $a Health Sciences, Pharmacy. $3 1017737
690 $a 0572
710 2 0 $a The University of Texas at Austin. $3 718984
773 0 $t Dissertation Abstracts International $g 67-06B.
790 $a 0227
790 1 0 $a Shepherd, Marvin D., $e advisor
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3223007